FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, namely to a celandine preparation for treatment of bladder cancer. The celandine preparation for treatment of bladder cancer consisting of fresh or fermented celandine herb juice, isotonic 0.9% water solution of sodium chloride, dimethyl sulfoxide, wherein the celandine herb juice and the isotonic solution of 0.9% water solution of sodium chloride are included at equal volumes, and dimethyl sulfoxide in an amount of 5% wt., the resulting solution is ultrasonicated at a frequency of 20 to 44 kHz with an acoustic power density of 1 to 10 W/cm3 for 30 to 300 s at a temperature not exceeding 50°С.
EFFECT: described preparation is effective for treatment of bladder cancer, bacteria-free and stable.
1 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING MALIGNANT NEOPLASMS | 2017 |
|
RU2654701C1 |
METHOD OF TREATMENT OF SUPERFICIAL CANCER OF BLADDER | 2007 |
|
RU2350338C2 |
METHOD OF TREATING BLADDER CANCER | 2014 |
|
RU2581946C2 |
METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER | 2013 |
|
RU2560314C2 |
METHOD FOR ENDOSCOPIC TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER | 2014 |
|
RU2556612C1 |
METHOD OF TREATING MALIGNANT BLADDER TUMOURS | 2009 |
|
RU2405601C1 |
METHOD OF POSTOPERATIVE THERAPY OF NON-MUSCLE INVASIVE BLADDER CANCER | 2009 |
|
RU2443423C2 |
METHOD OF TRANSURETHRAL RESECTION OF URINARY BLADDER WALL WITH URETERAL ORIFICE WITH APPLICATION OF TULIUM FIBER LASER IN LAPAROSCOPIC NEPHROURETERECTOMY FOR TREATMENT OF PATIENTS WITH HIGH URINARY CANCER OF HIGH DEGREE OF MALIGNANCY | 2019 |
|
RU2716349C1 |
METHOD OF EVALUATING EFFICIENCY OF INTRAMURAL AUTOPLASMOCHEMICAL THERAPY OF URINE BLADDER CANCER | 2009 |
|
RU2398517C1 |
METHOD OF TREATING SUPERFICIAL URINARY BLADDER CANCER | 2010 |
|
RU2448745C2 |
Authors
Dates
2021-05-11—Published
2020-06-08—Filed